,5,6,8 The loss of SMARCA4 (BRG1) and SMARCA2 (BRM) protein is pathognomonic for SCCOHT amongst other gynecologic cancers and histopathologic mimics.4 Here, SMARCA4 is linked to female reproductive organ cancer.